KRAS and lung cancer: This finding is similar to a study that showed the cumulative incidence of brain metastasis was higher in HER2 mutant lung cancer compared to KRAS and EGFR mutant lung cancer.30 This highlights the potential importance of monitoring for central nervous system metastases postoperatively in patients with NSCLC, particularly those with specific mutations.